Skip to content

Functional Nasal Surgery at the Time of Le Fort I Osteotomy: A Prospective, Single-blind, Randomized Trial

Functional Nasal Surgery at the Time of Le Fort I Osteotomy: A Prospective, Single-blind, Randomized Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01883687
Enrollment
80
Registered
2013-06-21
Start date
2013-06-30
Completion date
2017-04-30
Last updated
2013-06-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgical Procedure, Unspecified

Brief summary

Objectives: The aims of this study are (1) to define the effectiveness of functional nasal surgery during Le Fort I osteotomy on nasal obstruction through objective as well as subjective evaluations, (2) to determine guideline for concomitant functional nasal surgery with Le Fort I osteotomy, and (3) to explore possible mechanisms by which functional nasal surgery may reduce nasal obstruction severity. Design: A prospective, single-blnd, randomized trial. Setting: Chang Gung Craniofacial Center and Department of Otolaryngology (ENT). Patients: A total of 80 Taiwanese patients with unilateral cleft lip and palate and dentofacial deformity (age \>16 for females, \>18 for males; 40 in experimental and 40 in control groups) Interventions: In the experimental group, all patients will receive Le Fort I osteotomy and septoplasty. In the control group, all patients will receive Le Fort I osteotomy only. Measurements: All patients will undergo history taking, clinical examination, radioallergosorbent (RAST) examination (before surgery), standard questionnaire and image examination before surgery, one week, 1, 3, 6, 12 and 24 months after surgery. To reduce radiation exposure, cone-beam CT will only be performed before surgery and one week, 12 and 24 months after surgery. Data Analysis: Independent t and chi-squared tests, correlation coefficients and repeated measures analysis of variance (ANOVA) will be used. Statistical significance is assumed for a p value of less than 0.05. Key Words: cleft lip palate, nasal septum deviation, Le Fort I osteotomy, septoplasty, effectiveness

Interventions

PROCEDURESeptoplasty

Sponsors

Chang Gung Memorial Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
16 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Taiwanese adults with dentofacial deformities (DFD) 2. Have documented nasal obstruction and a hypertrophied inferior turbinate on the contralateral side of the septal deviation 3. Will undergo bimaxillary surgery including 1-piece Le Fort I osteotomy for DFD at the Craniofacial Center between 2012 and 2013

Exclusion criteria

1. Previous OGS or nasal surgery 2. Patients with nasal polyposis, rhinosinusitis or neoplasia 3. Patients with clefts or craniofacial anomaly 4. Patients with adenoid hypertrophy, nasal valve collapse, uncontrolled asthma or tobacco use 5. Noncompliance for test 6. Noncompliance to test schedule 7. Won't sign informed consent

Design outcomes

Primary

MeasureTime frameDescription
Changes in symptom severity and health-related quality of life in sinonasal conditionsbefore surgery and 24 months after surgerySino-Nasal Outcome Test 22(SNOT-22) questionnaire will be used

Secondary

MeasureTime frameDescription
Changes in nasal patency and congestionbefore surgery and 24 months after surgeryAcoustic rhinometry will be used
Changes of nasal airway volumebefore surgery and 24 months after surgery
Changes in transnasal pressure and airway resistance and pressure-flow characteristicsbefore surgery and 24 months after surgeryRhinomanometry will be used
Changes of causative allergensbefore surgery and 24 months after surgeryRAST examination will be used

Countries

Taiwan

Contacts

Primary ContactYu-Fang Liao, PHD
yufang@cgmh.org.tw+886-3-3196200

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026